Differential effect of national cholesterol education program (NCEP) step II diet on HDL cholesterol, its subfractions, and apoprotein A-I levels in hypercholesterolemic women and men after 1 year: The beFIT study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 6, 2000, Pages 1580-1587

  Walden, Carolyn E ^a   Retzlaff, Barbara M ^a   Buck, Brenda L ^a   Wallick, Shari ^a   McCann, Barbara S ^b   Knopp, Robert H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

ApoA I; Combined hyperlipidemia; HDL cholesterol; Hypercholesterolemia; Low fat diet

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; DIETARY INTAKE; DRUG EFFECT; FAT INTAKE; FEMALE; FRACTIONATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034084116     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.6.1580     Document Type: Article

References (52)

1. US Bureau of the Census. Statistical Abstract of the United States. Washington, DC: US Bureau of the Census; 1997.
2. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344: 1383-1389.
3. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301-1307.
4. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole G, Brown L, Warnica JW, Arnold JM, Wun CC, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335:1001-1009.
5. US Department of Health and Human Services. Healthy People 2000: National Health Promotion and Disease Prevention Objectives. Washington, DC: US Department of Health and Human Services; 1991.
6. Sempos CT, Cleeman JI, Carroll MD, Johnson CL, Bachorik PS, Gordon DJ, Burt VL, Briefel RR, Brown CD, Lippel K, et al. Prevalence of high blood cholesterol among US adults: an update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel [see comments]. JAMA. 1993;269:3009-3014.
7. Walden CE, Retzlaff BM, Buck BL, McCann BS. Knopp RH. Lipoprotein response to the National Cholesterol Education Program Step II diet by hypercholesterolemic and combined hyperlipidemic women and men. Arterioscler Thromb Vasc Biol. 1997;17:375-382.
8. Wood PD, Stefanick ML, Williams PT, Haskell WL. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med. 1991;325: 461-466.
9. Hunninghake DB, Stein EA, Dujovne CA, Harris WS, Feldman EB, Miller VT, Tobert JA, Laskarzewski PM, Quiter E, Held J, et al. The efficacy of intensive diet therapy alone or in combination with lovastatin in outpatients with hypercholesterolemia. N Engl J Med. 1993;328: 1213-1219.
10. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, Contois JH, Li Z, Rasmussen H, McNamara JR, Ordovas JM. Efficacy of a National Cholesterol Education Program Step 2 diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and women. Arterioscler Thromb Vasc Biol. 1995;15:1079-1085.
11. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res. 1982;23:1206-1223.
12. Martini S, Baggio G, Baroni L, Enzi GB, Fellin R, Baiocchi MR, Crepaldi G. Evaluation of HDL2 and HDL3 cholesterol by a precipitation procedure in a normal population and in different hyperlipidemic phenotypes. Clin Chem Acta. 1984;137:291-298.
13. Haffner SM, Applebaum-Bowden D, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Hazzard WR. Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase: effects of smoking, alcohol, and adiposity. Arteriosclerosis. 1985;5:169-177.
14. Diehl AK, Fuller JH, Mattock MB, Salter AM, el-Gohari R, Keen H. The relationship of high density lipoprotein subfractions to alcohol consumption, other lifestyle factors, and coronary heart disease. Atherosclerosis. 1988;69:145-153.
15. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62:707-714.
16. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ. HDL cholesterol and other lipids in coronary heart disease: the cooperative lipoprotein phenotyping study. Circulation. 1977;55:767-772.
17. Miller NE, Thelle DS, Forde OH, Mjos OD. The Tromso heart-study: high-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet. 1977;1:965-968.
18. Bass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med. 1993; 153:2209-2216.
19. Jacobs DR, Jr, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol. 1990;131:32-47.
20. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989;79:8-15.
21. Lipid Metabolism Branch, Division of Heart, and Vascular Diseases, National Heart, Lung, and Blood Institute. The Lipid Research Clinics Population Studies Data Book, Volume 1: The Prevalence Study: Aggregate Distribution of Lipids, Lipoproteins and Selected Variables in 11 North American Populations. Bethesda, MD: Department of Health and Human Services, Public Health Service, National Institutes of Health; 1980;1-136.
22. Schakel SF, Sievert YA, Buzzard IM. Sources of data for developing and maintaining a nutrient database. J Am Diet Assoc. 1988;88:1268-1271.
23. Warnick GR. Enzymatic methods for quantification of lipoprotein lipids. In: Segrest JP, Albers JJ, eds. Methods in Enzymology, Part B: Characterization, Cell Biology, and Metabolism. New York, NY: Academic Press Inc; 1986;129:101-123.
24. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
25. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 1993;269:3015-3023.
26. Black AE, Prentice AM, Goldberg GR, Jebb SA, Bingham SA, Livingstone MB, Coward WA. Measurements of total energy expenditure provide insights into the validity of dietary measurements of energy intake. J Am Diet Assoc. 1993;93:572-579.
27. Kretsch MJ, Fong AK, Green MW. Behavioral and body size correlates of energy intake underreporting by obese and normal-weight women. J Am Diet Assoc. 1999;99:300-306.
28. Geil PB, Anderson JW, Gustafson NJ. Women and men with hypercholesterolemia respond similarly to an American Heart Association step 1 diet. J Am Diet Assoc. 1995;95:436-441.
29. Cole TG, Bowen PE, Schmeisser D, Prewitt TE, Aye P, Langenberg P, Dolecek TA, Brace LD, Kamath S. Differential reduction of plasma cholesterol by the American Heart Association Phase 3 Diet in moderately hypercholesterolemic, premenopausal women with different body mass indexes. Am J Clin Nutr. 1992;55:385-394.
30. Morgan SA, O'Dea K, Sinclair AJ. A low-fat diet supplemented with monounsaturated fat results in less HDL-C lowering than a very-low-fat diet [see comments]. J Am Diet Assoc. 1997;97:151-156.
31. Cobb M, Greenspan J, Timmons M, Teitelbaum H. Gender differences in lipoprotein responses to diet. Ann Nutr Metab. 1993;37:225-236.
32. Kuusi T, Ehnholm C, Huttunen JK, Kostiainen E, Pietinen P, Leino U, Uusitalo U, Nikkari T, Iacono JM, Puska P. Concentration and composition of serum lipoproteins during a low-fat diet at two levels of polyunsaturated fat. J Lipid Res. 1985;26:360-367.
33. Jones DY, Judd JT, Taylor PR, Campbell WS, Nair PP. Influence of caloric contribution and saturation of dietary fat on plasma lipids in premenopausal women. Am J Clin Nutr. 1987;45:1451-1456.
34. Brussaard JH, Katan MB, Groot PH, Havekes LM, Hautvast JG. Serum lipoproteins of healthy persons fed a low-fat diet or a polyunsaturated fat diet for three months: a comparison of two cholesterol-lowering diets. Atherosclerosis. 1982;42:205-219.
35. Ginsberg HN, Kris-Etherton P, Dennis B, Elmer PJ, Ershow A, Lefevre M, Pearson T, Roheim P, Ramakrishnan R, Reed R, et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol. 1998;18:441-449.
36. Denke MA, Grundy SM. Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia. Arch Intern Med. 1994;154:317-325.
37. Denke MA. Individual responsiveness to a cholesterol-lowering diet in postmenopausal women with moderate hypercholesterolemia. Arch Intern Med. 1994;154:1977-1982.
38. Stefanick ML, Mackey S, Sheehan M, Ellsworth N, Haskell WL, Wood PD. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol [see comments]. N Engl J Med. 1998;339:12-20.
39. Clifton PM, Nestel PJ. Influence of gender, body mass index, and age on response of plasma lipids to dietary fat plus cholesterol. Arterioscler Thromb. 1992;12:955-962.
40. Clifton PM, Abbey M, Noakes M, Beltrame S, Rumbelow N, Nestel PJ. Body fat distribution is a determinant of the high-density lipoprotein response to dietary fat and cholesterol in women. Arterioscler Thromb Vasc Biol. 1995;15:1070-1078.
41. Patsch W, Sharrett AR, Sorlie PD, Davis CE, Brown SA. The relation of high density lipoprotein cholesterol and its subfractions to apolipoprotein A-I and fasting triglycerides: the role of environmental factors: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1992; 136:546-557.
42. Buring JE, O'Connor GT, Goldhaber SZ, Rosner B, Herbert PN, Blum CB, Breslow JL, Hennekens CH. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction. Circulation. 1992;85:22-29.
43. Maciejko JJ, Holmes DR, Kottke BA, Zinsmeister AR, Dinh DM, Mao SJ. Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med. 1983;309:385-389.
44. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction [see comments]. N Engl J Med. 1991;325:373-381.
45. Wallentin L, Sundin B. HDL2 and HDL3 lipid levels in coronary artery disease. Atherosclerosis. 1986;59:131-136.
46. Retzlaff B, Walden CE, Dowdy AA, McCann BS, Anderson KA, Knopp RH. Changes in plasma triacylglycerol concentrations among free-living hyperlipidemic men adopting different carbohydrate intakes over 2 y: the Dietary Alternatives Study. Am J Clin Nutr. 1995;62:988-995.
47. Knopp RH, Walden CE, Retzlaff BM, McCann BS, Dowdy AA, Albers JJ, Gey GO, Cooper MN. Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men: the Dietary Alternatives Study. JAMA. 1997;278:1509-1515.
48. Vélez-Carrasco W, Lichtenstein AH, Welty FK, Li Z, Lamon-Fava S, Dolnikowski GG, Schaefer EJ. Dietary restriction of saturated fat and cholesterol decreases HDL apoA-I secretion. Arterioscler Thromb Vasc Biol. 1999;19:918-924.
49. Brinton EA, Eisenberg S, Breslow JL. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. J Clin Invest. 1990;85:144-151.
50. Rigotti A, Krieger M. Getting a handle on 'good' cholesterol with the high-density lipoprotein receptor, N Engl J Med. 1999;341: 2011-2013.
51. Spady DK, Kearney DM, Hobbs HH. Polyunsaturated fatty acids up-regulate hepatic scavenger receptor B1 (SR-BI) expression and HDL cholesteryl ester uptake in the hamster. J Lipid Res. 1999l;40: 1384-1394.
52. Knopp RH. Drug treatment of lipid disorders. N Engl J Med. 1999;341: 498-511.